The legendary @devlinpharmd reminds us of the importance of distinguishing between causal and hypothesis generating findings - outstanding talk on delirium in ICU 🇰🇼 CriticalCareKuwait

Not a surprise…another incredibly layout talk by the talented Patrick Wieruszewski on redefining the use vasopressor use CriticalCareKuwait #Criticalcarekuwait2025 🇰🇼 our approach to their use has changed because of the great work done recently!

🎉Our manuscript on protective hemodynamics on Journal of Cardiothoracic and Vascular Anesthesia The C.L.E.A.R. strategy! Giacomo Monti Giovanni Landoni, MD Marilena Marmiere, MD

🚨 New Review Alert Stay updated on the evolving landscape of Thoracoabdominal aortic aneurysm (#TAAA) management and read the full review to explore the latest insights! 📥 oaepublish.com/articles/2574-… #EndovascularRepair #Aneurysm #VascularSurgery #MedicalResearch #Cardiovascular

🙏😇 to be part of the #1 Cardiac Surgery Program - Newsweek Rankings ⁦⁦Mayo Clinic⁩ #1 🔝 🫀🫁 ⁦MayoAnesthesiaResMN⁩ ⁦Mayo Clinic Department of Anesthesiology⁩ ⁦Mayo Clinic Cardiac Surgery⁩ newsweek.com/rankings/world…

‼️our group is growing and hiring another pharmacist ‼️ covers thoracic transplant and cardiac surgery ICU! 🫁🫀come join the amazing team - 84 lung transplants in 2024! Mayo Clinic Cardiac Surgery Mayo Clinic Department of Anesthesiology Mayo Clinic Pharmacy Residency Programs - Deadline Feb 28 - happy to answer questions. RT please!! 👉🏼

I had the honor of presenting at the 1st Pan Arab Critical Care Conference in Kuwait. A world-class conference in critical care. I am deeply grateful to my colleague, Dr. Afrah Alkazemi for the invitation to participate in this inspiring event led by the esteemed Abdulrahman Al-Fares

Great STAR research presentation from @devlinpharmd using big claims data - non-opioid analgesics are underutilized in surgical patients requiring ICU admission, even when full opioid agonists are prescribed. We need to do better! #SCCM2025 #PharmICU

How do you we identify patients more likely to respond to angiotensin II? 🤔 Excited to share our work, signaling ⬇️ ICU and 30-day mortality in patients requiring renal replacement therapy that receive it compared to standard of care! Find it here: sciencedirect.com/science/articl…

Another interesting article on Journal of Cardiothoracic and Vascular Anesthesia suggesting potential benefit of Ang II in patients requiring RRT Similar findings were reported by #ATHOS investigators on Critical Care Medicine: journals.lww.com/ccmjournal/ful… Ashish K. Khanna, MD,MS,FCCP,FCCM,FASA Giovanni Landoni, MD Patrick Wieruszewski Thomas Hanff, MD MSCE San Raffaele Anesthesia and Intensive Care

Honored to be inducted as Fellow in the American College of Critical Care Medicine! SCCM Forever grateful to my caring and loving wife Erin Wieruszewski, family, friends, mentors, and colleagues for supporting me to make it possible! Mayo Clinic Department of Anesthesiology SCCM Clinical Pharmacy and Pharmacology Section

🚨Hot off the press 👇Mayo Clinic Department of Anesthesiology Mass General Anesthesia Mass General Brigham Research Christoph G. S. Nabzdyk Patrick Wieruszewski Juan G. Ripoll, MD

Really enjoyed leading this paper with a great group of Mayo colleagues Patrick Wieruszewski Juan G. Ripoll, MD

🌟 FCCM Spotlight: Patrick M. Wieruszewski, PharmD, BCCCP, FCCM 🌟​ ​Patrick is a clinical pharmacist and appointed associate in the cardiothoracic surgery ICU and ECMO program at Mayo Clinic and serves as Chairman for Clinical Pharmacy Research at Mayo Clinic. #PharmICU

Mayo Clinic He has dual academic appointment as Assistant Professor in the fields of Anesthesiology and Pharmacy in the Mayo Clinic College of Medicine. 🎓 #PharmICU

Mayo Clinic His research focuses on the understanding of human circulatory physiology, hemodynamic dysregulation, and vascular dysfunction. 📊 #PharmICU

Mayo Clinic In his personal time, he enjoys spending time with his wife and two golden retrievers, weightlifting, and traveling. 🐕 #PharmICU

#ECMO in pulmonary embolism: 🩺 rationale & current trends 📄 ECMO in PE treatment guidelines ⏱️ timing of ECMO: reactive vs proactive? 🩸 standalone, bridge to reperfusion, post-treatment support for organ recovery? 💉 concomitant systemic thrombolytics ☢️ concomitant

Analysis of 2024 EACTS/EACTAIC/EBCP Guidelines on Cardiopulmonary Bypass in 🔍 How do we balance bleeding vs. thrombosis risk? 💉 When should we reverse DOACs or bridge VKAs? 👥 Why is shared decision-making critical? jcvaonline.com/article/S1053-… #CardiacAnesthesia #CPB

Direct Thrombin Inhibitors in #ECMO 🔎 SR/MA of studies comparing DTIs vs UFH 🔍 28 studies identified, most (25) on bivalirudin 🩸DTIs achieved therapeutic anticoagulation range faster + maintained therapeutic range for > time ⚖️ effects similarly significant in adults (not in